on 24 Apr 2024
Last Applicant/ Owned by
200 Smith Street
Waltham
US
02451
Serial Number
98238959 filed on 25th Oct 2023
Registration Number
N/A
Correspondent Address
Karen WonMINTZ, LEVIN, COHN, ERRIS, GLOVSKY, AN POPEO P.C
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating andRead More
Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVH), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
No 98238959
No Service/Collective Mark
No 062902-400
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
20th Apr 2024 | APPROVE OR PUB - PRINCIPAL REGISTER |
12th Apr 2024 | TEAS RESPONSE TO OICE ACTION RECEIVE |
12th Apr 2024 | TEAS/EMAIL CORRESPONENCE ENTERE |
12th Apr 2024 | CORRESPONENCE RECEIVE IN LAW OICE |
13th Jan 2024 | NON-INAL ACTION E-MAILE |
13th Jan 2024 | NON-INAL ACTION WRITTEN |
13th Jan 2024 | NOTIICATION O NON-INAL ACTION E-MAILE |
12th Jan 2024 | ASSIGNE TO EXAMINER |
31st Oct 2023 | NEW APPLICATION OICE SUPPLIE ATA ENTERE |
28th Oct 2023 | NEW APPLICATION ENTERE |